---

Related Articles:

Oxaceprol, an atypical inhibitor of inflammation, reduces leukocyte adherence in mouse antigen-induced arthritis.

2001-06-01

[Acta Orthop. Scand. 72(3) , 293-8, (2001)]

Determination of oxaceprol in rat plasma by LC-MS/MS and its application in a pharmacokinetic study.

2011-01-05

[J. Pharm. Biomed. Anal. 54(1) , 173-8, (2011)]

[Assessment of the placebo effect of symptomatic slow-acting anti-arthritics].

1998-02-07

[Presse Med. 27(5) , 211-4, (1998)]

Oxaceprol is a well-tolerated therapy for osteoarthritis with efficacy equivalent to diclofenac.

2000-01-01

[Clin. Rheumatol. 19(2) , 99-104, (2000)]

Oxaceprol--a randomised, placebo-controlled clinical study in osteoarthritis with a non-conventional non-steroidal anti-inflammatory drug.

2007-01-01

[Clin. Exp. Rheumatol. 25(1) , 29-34, (2007)]